CYCLIC THROMBOCYTOPENIA ASSOCIATED WITH IGM ANTI-GPIIB-IIIA AUTOANTIBODIES
Citation
S. Kosugi et al., CYCLIC THROMBOCYTOPENIA ASSOCIATED WITH IGM ANTI-GPIIB-IIIA AUTOANTIBODIES, British Journal of Haematology, 88(4), 1994, pp. 809-815
Categorie Soggetti
Hematology
SICI code
0007-1048(1994)88:4<809:CTAWIA>2.0.ZU;2-#
Abstract
We studied a female patient with cyclic fluctuation in platelet count
following splenectomy for autoimmune thrombocytopenia. The cyclical fl
uctuation appeared to be in phase with her menstrual cycle and her pla
telet count was low during menses. Bone marrow examinations performed
at the peak as well as the bottom of the platelet count showed normal
or increased numbers of megakaryocytes. The patient's platelet count i
ncreased rapidly after intravenous gamma-globulin (IVIgG) therapy, sug
gesting that a failure of platelet production is unlikely to account f
or the cycle. Platelet-associated IgM (PAIgM) was markedly elevated, w
hereas PAIgG was normal at any stage of the cycle. MACE assay demonstr
ated that PAIgM contained IgM anti-glycoprotein (GP) IIb-IIIa autoanti
bodies. Comparison between MACE assay using untreated and EDTA-treated
platelets at 37 degrees C demonstrated that the platelet-associated I
gM autoantibodies mainly recognized divalent cation-dependent conforma
tion(s) of GPIIb-IIIa. No antibodies were, however, detected in her se
rum. The levels of IgM anti-GPIIb-IIIa showed an inverse relationship
with the platelet count. In spite of the marked increase in platelet c
ount after IVIgG, however, the levels of IgM anti-GPIIb-IIIa remained
elevated. These findings suggest that platelet-associated IgM antiGPII
b-IIIa autoantibodies are of pathogenic significance in this patient.